Value investing, read from the source.
Focused Compounding tracks investing through primary documents, stock examples, and long-cycle business judgment. Recent episodes move from Berkshire Hathaway letters and 13F filings to rate cuts, IPOs, micro-caps, and distressed companies.
PRESS PLAY
Focused Compounding is an investing show built around close reading and long-term business judgment. Its natural habitat is the shareholder letter, the 13F filing, the company write-up, and the awkward market question that does not have a clean answer yet. Andrew Kuhn and Jeff Gannon move through those materials in a conversational way, usually starting from a fresh market event or a document on screen. The tone is informal, but the subject matter is precise. Recent episodes spend serious time on Jamie Dimon’s JPMorgan shareholder letter, Greg Abel’s first Berkshire Hathaway shareholder letter, Buffett’s Thanksgiving letter, and the transition into Berkshire’s next chapter. Berkshire is a recurring anchor. So are questions about who bought what, why a stock appears in a filing, and whether a move really fits Buffett’s usual pattern. The show also follows broader conditions, including Federal Reserve rate cuts, sticky inflation, IPO windows, and the way market cycles change what can get financed. It is strongest when a single example opens into a bigger investing principle. U.S. Lime becomes a discussion about micro-cap quality, scale, and re-rating. Reddit becomes a way to think about older internet platforms finally entering public markets. 13F season becomes a map of quality investors, capital allocators, low-price lists, and names clustered around 52-week lows. Bankruptcy investing gets treated as an analytical discipline rather than a dramatic headline. The hosts often reference tools and source material such as QuickFS, DataRoma, filings, and archived investment write-ups. That gives the show a working-investor feel. It assumes patience from the audience. It rewards listeners who like hearing uncertainty handled in real time, including caveats about who likely made a purchase, how much a filing can reveal, and when a stock’s quality may already be reflected in the price. The show is not lifestyle finance and it is not quick trading commentary. It is a steady room for value investors who care about durable businesses, management communication, capital allocation, and price versus quality. The conversations can be granular. That is the point. Focused Compounding turns current market material into case studies for investors who would rather examine the evidence than chase the loudest narrative.
Made for: Focused Compounding is for serious individual investors, value investors, and business-analysis obsessives who enjoy filings, shareholder letters, and company-specific reasoning. It best suits listeners comfortable with detailed market talk and patient discussion.
What sets it apart: The show stands apart by working from primary materials and named company examples instead of broad market slogans. Berkshire letters, 13F filings, QuickFS screens, and archived write-ups become the basis for practical investing judgment.
QuickFS Link: https://quickfs.net/?via=focusedTwitter: @FocusedcompoundEmail: [email protected] Compounding is an exclusive, members-only site for buy and hold value investors. Inside, you will find research writeups written by hedge fund manager, Geoff Gannon. Experience all this in the company of investors who follow the principles of Buffett, Munger, and Fisher instead of the whims of the crowd.Please read our Disclaimer: https://focusedcompounding.com/disclaimer/
Short reviews from the PlayNext desk, based on the episodes we processed.
A clear tour of 13F season, 52-week lows, and capital-allocation clues in familiar holdings.
Focused Compounding treats 13F season as a useful way to watch how other fund managers are shifting capital. Andrew Kuhn and Jeff Gannon begin with the filing threshold, an investment portfolio over $100 million on US exchanges, then tie it to Charlie Munger's advice to study…
A measured warning about expensive markets and the danger of assuming a cheaper comparable has to catch up.
Focused Compounding sits with a market that still looks priced near its expensive edge. Andrew Kuhn and Jeff Gannon treat that setup as fragile, especially if expectations are already built around a very good outcome.
A clear first-pass look at how venues, leases, cash flow, and debt shape the investment case for Dave & Buster's.
Paramount speculation opens the Focus Compounding conversation, but Andrew Kuhn and Jeff Gannon soon move into a practical look at Dave & Buster's and the economics behind a family entertainment center.
Demetri Kofinas interviews specialists on geopolitics, energy markets, AI, and finance at length.
BBC's daily business show, from toy-industry founders to Anthropic's Pentagon standoff.
Hosts Andrew Kuhn and Geoff Gannon analyze recent M&A activity in media, focusing on new bids for Paramount.
Andrew Kuhn and Jeff Gannon reflect on 2023 and discuss predictions for 2024 in this year-end investing podcast.
Andrew Kuhn and Jeff Gannon discuss how to create a disciplined investing plan for those with only an hour a day to invest.
Andrew Kuhn and Geoff Gannon discuss the yen carry trade blowup that rattled global markets, including an 11% drop in Japanese stocks.
Andrew Kuhn and Jeff Gannon discuss Jamie Dimon's lengthy annual shareholder letter for JPMorgan, analyzing its content and the effort behind writing it.
Andrew Kuhn and Jeff Gannon discuss Greg Abel's first Berkshire Hathaway shareholder letter, comparing it to Buffett's style and noting potential changes in how Berkshire presents stock holdings.
Andrew Kuhn and Jeff Gannon discuss recent market events including AI capital expenditure, the Netflix/Warner Bros.
Andrew Kuhn and Jeff Gannon discuss Warren Buffett's announcement that he will step back from writing Berkshire Hathaway's annual letter and hand over CEO duties to Greg Abel at year-end.
Andrew Kuhn and Jeff Gannon review the Fed's 25-basis-point cut, which brought the rate to "four and a quarter", with four more cuts priced in.
Focused Compounding’s “Ep 470.
Andrew Kuhn and Jeff Gannon open Focused Compounding Ep 468 with Crocs, whose stock fell 25% after it guided Q3 2025 revenue down 9% to 11% despite 3.4% top-line growth.
Andrew Kuhn opens by noting Palantir trades at about 118 times price to sales on a $370 billion market cap, which Jeff Gannon says is beyond anything he has charted, since his own general ceiling is 10 times sales.
Andrew Kuhn and Jeff Gannon discuss bankruptcy investing strategies and analyze Reddit's recent IPO.
Andrew Kuhn and Jeff Gannon discuss navigating three rate cuts with sticky inflation in 2024 and analyze U.S.
Andrew Kuhn and Jeff Gannon discuss the proxy battle between Robert Young and New York Central in 1954, continuing their Dear Chairman series.